In some cell systems, the antiproliferative effects of 8-Cl-cAMP, a site-selective cAMP analog speci®c for the type I cAMP-dependent protein kinase, are mediated by its metabolite, 8-Cl-adenosine. These effects were once thought to be speci®c to transformed cells. We investigated the ability of 8-Cl-adenosine to regulate growth and differentiation in primary cultures of mouse epidermal keratinocytes. A 24 h exposure of keratinocytes to 8-Cl-adenosine inhibited [ 3 H]thymidine incorporation in a dose-dependent manner with an apparent IC 50 of 7.5 mM, and these effects were completely reversible. To determine the ability of 8-Cl-adenosine to induce differentiation of primary keratinocytes, we measured keratin-1 expression and transglutaminase activity, markers of early and later stages of keratinocyte differentiation, respectively. Interestingly, exposure of keratinocytes to 25 mM 8-Cl-adenosine for 24 h had no effect on keratin-1 expression or transglutaminase activity. The 8-Cladenosine-induced growth arrest of keratinocytes required uptake of the compound and was accompanied by an increase in protein expression of the cyclin-dependent protein kinase inhibitor p21 WAF1/Cip1 . These results demonstrate that 8-Cladenosine inhibits growth in a nontransformed/nonimmortalized cell system, possibly through an elevation in p21 WAF1/Cip1 protein levels, without inducing differentiation. Key words: cell cycle/keratin-1/ p21 WAF1/Cip1 /transglutaminase. J Invest Dermatol 117: 1588±1593, 2001 
In some cell systems, the antiproliferative effects of 8-Cl-cAMP, a site-selective cAMP analog speci®c for the type I cAMP-dependent protein kinase, are mediated by its metabolite, 8-Cl-adenosine. These effects were once thought to be speci®c to transformed cells. We investigated the ability of 8-Cl-adenosine to regulate growth and differentiation in primary cultures of mouse epidermal keratinocytes. A 24 h exposure of keratinocytes to 8-Cl-adenosine inhibited [ 3 H]thymidine incorporation in a dose-dependent manner with an apparent IC 50 of 7.5 mM, and these effects were completely reversible. To determine the ability of 8-Cl-adenosine to induce differentiation of primary keratinocytes, we measured keratin-1 expression and transglutaminase activity, markers of early and later stages of keratinocyte differentiation, respectively. Interestingly, exposure of keratinocytes to 25 mM 8-Cl-adenosine for 24 h had no effect on keratin-1 expression or transglutaminase activity. The 8-Cladenosine-induced growth arrest of keratinocytes required uptake of the compound and was accompanied by an increase in protein expression of the cyclin-dependent protein kinase inhibitor p21 WAF1/Cip1 . These results demonstrate that 8-Cladenosine inhibits growth in a nontransformed/nonimmortalized cell system, possibly through an elevation in p21 WAF1/Cip1 protein levels, without inducing differentiation. Key words: cell cycle/keratin-1/ p21 WAF1/Cip1 /transglutaminase. J Invest Dermatol 117: 1588±1593, 2001 R ecently, much attention has been focused on the use of nontoxic biologic agents that may potentially restore regulatory control to cellular proliferation in neoplastic cells. One such biologic agent, 8-Cl-cAMP, has gained considerable attention due to its potent antiproliferative properties against transformed cells. An initial phase I clinical trial using 8-Cl-cAMP as an antineoplastic drug has been performed (Tortora et al, 1995) . Important, though, are the observations that in some cells the antiproliferative effects of 8-Cl-cAMP are mediated by its metabolite, 8-Cl-adenosine. For example, the 8-Cl-cAMP-induced inhibition of proliferation and downregulation in mdr1 expression in the breast cancer cell line MCF7 is blocked if adenosine deaminase activity, which converts adenosine to inosine, is elevated in the culture medium (Scala et al, 1995) . Also, 8-Cl-cAMP-mediated inhibition of proliferation in CHO cells is almost completely blocked when the cells are cultured in either serum-free conditions or medium containing heat-inactivated serum (Van Lookeren Campagne et al, 1991) , conditions that reduce or eliminate phosphodiesterase activity and inhibit the conversion of 8-Cl-cAMP to 8-Cl-adenosine. Along these same lines, use of a phosphodiesterase-resistant form of 8-Cl-cAMP, Sp-8-Cl-cAMP, but not the parental compound, failed to inhibit proliferation in the colorectal cancer cell line LS174T (Carlson et al, 2001) . And ®nally, 8-Cl-cAMP-induced inhibition of proliferation of nontransformed ®broblast, myoblast, and endothelial cells is dependent upon its conversion to 8-Cl-adenosine (Han et al, 1993) . Thus, in some cell systems, the antiproliferative effects of 8-Cl-cAMP apparently are mediated by 8-Cl-adenosine. In addition, it was once thought that the antiproliferative effects of this nucleoside were speci®c to transformed cells; however, 8-Cl-adenosine inhibits proliferation in normal ®broblast, myoblast, and endothelial cells (Han et al, 1993) , as well as in both nontransformed and c-ras-transformed 3T3 cells (Noguchi et al, 1998) .
Primary epidermal keratinocytes represent a nontransformed cell type that proliferates as part of its normal function. Speci®cally, these cells continuously divide in vivo to regenerate epidermal cells lost to the environment. Keratinocytes also differentiate in culture in response to several agents (e.g., gangliosides G T1b and G Q1b , elevated medium Ca 2+ levels, and 1,25-dihydroxyvitamin D 3 ). These agents can induce markers of both early (e.g., keratin-1 and keratin-10 expression) and late (e.g., transglutaminase activity) differentiation (Yada et al, 1991; Paller et al, 1995; and reviewed in Bikle and Pillai, 1993) . In general, agents that induce keratinocyte growth arrest also trigger the complete program of differentiation; however, these two processes can be dissociated in the case of some keratinocyte regulators. For example, transforming growth factor b (TGF-b) induces growth arrest without an accompanying increase in the expression of keratinocyte differentiation markers (Bikle and Pillai, 1993; Hu et al, 1998) ; however, the mechanism of this dissociation is unknown.
As discussed above, in many cell types the antiproliferative effects of 8-Cl-cAMP are mediated by its metabolite, 8-Cl-adenosine. In addition, adenosine and its related adenine nucleotides (ATP, ADP, AMP) inhibit proliferation in normal human keratinocytes (Cook et al, 1995; Brown et al, 2000) . The mechanism by which this occurs is unknown at this time, however. In light of these studies, we sought to determine if 8-Cl-adenosine exerted any antiproliferative effects against a nontransformed, nonimmortalized cell system, primary mouse keratinocytes. We found that 8-Cladenosine triggered reversible growth arrest of primary mouse epidermal keratinocytes without inducing an increase in markers of early or late differentiation. Thus, this compound appears to act in a similar manner to TGF-b but is a small nonpeptide molecule capable of inhibiting the proliferation of keratinocytes without affecting their differentiation status.
MATERIALS AND METHODS
Materials 8-Cl-adenosine was purchased from Biolog (La Jolla, CA). Anti-p21WAF1 (Ab-4), Oncogene Sciences (Cambridge, MA), and anti-p21 WAF1/Cip1 (13436E), Pharmingen (San Diego, CA), were used for this study. Cell culture Primary epidermal keratinocytes were prepared from 1to 3-d-old neonatal ICR mice according to the method of Marcelo et al (1978) . Brie¯y, after trypsinization of the skin, the epidermis was mechanically separated from the dermis and epidermal cells were released by scraping. These cells were then collected by centrifugation and plated in six-well dishes in keratinocyte medium consisting of minimum essential medium containing 25 mM Ca 2+ , 2% (vol/vol) dialyzed fetal bovine serum (FBS), 2 mM glutamine, 5 ng per ml epidermal growth factor, ITS + [6.25 mg per ml insulin, 6.25 mg per ml transferrin, 6.25 ng per ml selenious acid + 5.35 mg per ml linoleic acid + 0.125% (wt/vol) bovine serum albumin], 100 U per ml penicillin, 100 mg per ml streptomycin, and 0.25 mg per ml fungizone. After an overnight incubation, the cells were refed with serum-free keratinocyte medium (SFKM), in which 2% (vol/vol) dialyzed FBS was replaced with 90 mg per ml bovine pituitary extract. Cells were refed with fresh medium every 1±3 d.
Measurement of DNA synthesis For measurement of [ 3 H]thymidine incorporation, near-con¯uent cultures were refed with SFKM containing various concentrations of 8-Cl-adenosine. After the times indicated in the ®gure legends, cells were labeled with 1 mCi per ml [ 3 H]thymidine for an additional hour in the continued presence of 8-Cl-adenosine. Cultures were washed twice with phosphate-buffered saline without calcium or magnesium (PBS ± ) and reactions were terminated using icecold 5% trichloroacetic acid (TCA). Cells were washed with an additional volume of 5% TCA and with distilled water, and were solubilized in 0.3 M NaOH for 10 min at 50°C. The amount of [ 3 H]thymidine incorporated into DNA was determined by liquid scintillation counting.
Flow cytometric analysis Unsynchronized near-con¯uent cultures of keratinocytes were refed with SFKM containing the indicated agents. After 24 h, the media as well as one 1 Q PBS ± wash (to obtain¯oating cells) were collected. The attached cells were harvested and pooled with the cells that had become detached. In some experiments the media and the PBS ± wash were aspirated and only the attached cells were collected and processed for¯ow cytometric analysis. The combined cell pellet was washed once with ice-cold PBS ± , gently resuspended in ice-cold 70% EtOH, and stored at 4°C until processing. DNA content of the nuclei was determined by staining nuclear DNA with propidium iodide (50 mg per ml, 30 min) and measuring the relative DNA content of nuclei of 10,000 events, using a Becton Dickinson FACSCalibur¯uorescenceactivated cell sorter. MODFIT DNA and CELLQUEST analysis software were utilized to determine the proportion of nuclei in each phase of the cell cycle.
Western blot analysis Cellular proteins were quanti®ed using the Bio-Rad DC protein assay system (Bio-Rad, Hercules, CA), with bovine serum albumin as standard. Equal amounts of proteins (25±50 mg) were then resolved through 10% sodium dodecyl sulfate polyacrylamide gels and transferred to nitrocellulose using either a semidry or wet transfer apparatus. In the case of the p21 WAF1/Cip1 Westerns, electroblots were probed with anti-p21WAF1 (Ab-4) [diluted 1:100 in 1 Q PBS containing 2% (wt/vol) nonfat milk and 0.1% (vol/vol) Tween-20] for 16 h at 4°C. The blots were washed three times (10 min each) with 1 Q PBS/0.1% Tween-20 and exposed to goat antimouse horseradish peroxidase (diluted 1:5000 in 1 Q PBS containing 2% nonfat milk and 0.1% Tween-20) for 2 h at room temperature. The blots were washed again as described above. In this study, we also used an antimouse p21 WAF1/Cip1 antibody (13436E), according to the manufacturer's guidelines. Western blot analysis for keratin-1 (diluted 1:500) was performed using a previously described protocol (Towbin, 1979) . For the p21 WAF1/Cip1 Westerns, immunoreactive proteins were visualized using standard enhanced chemiluminescent techniques (SuperSignal, Pierce). Immunoreactive keratin-1 protein was visualized using 125 Ilabeled goat antirabbit IgG and quanti®ed by PhosphorImager analysis (Molecular Dynamics, Sunnyvale, CA).
Measurement of transglutaminase activity
Near-con¯uent keratinocytes were incubated for 24 h with the indicated agents in SFKM. The cells were washed with PBS ± , scraped into homogenization buffer [0.1 M Tris-acetate, pH 7.8, 2 mg per ml aprotinin, 2 mM leupeptin, 1 mM pepstatin A, 0.2 mM ethylenediamine tetraacetic acid (EDTA), 0.2 mM phenylmethylsulfonyl¯uoride, and 0.1% (vol/vol) b-mercaptoethanol], placed into microcentrifuge tubes, and pelleted by centrifugation. The supernatants were removed and the cell pellets were subjected to one freeze±thaw cycle prior to disruption by sonication in homogenization buffer. Aliquots of the homogenate were incubated overnight (16±18 h) at 37°C with 2 mCi per sample [ 3 H]putrescine in a reaction mixture containing 1% (wt/vol) dimethylated Hammerstein casein, 0.1 M Tris-acetate (pH 8.5), 10 mM CaCl 2 , 0.1 mM EDTA, 25 mM dithiothreitol, and 0.1% (vol/vol) Triton X-100 (®nal concentrations). Reactions were terminated by adding TCA (to a ®nal concentration of 5%) and the samples were ®ltered through glass-®ber ®lters. After thorough washing with 5% TCA, the ®lters were counted by liquid scintillation spectrometry. Cellular protein content of the samples was determined as described above.
Statistical analysis
The signi®cance of differences between mean values was determined using ANOVA, as performed by the program Instat (GraphPad Software, San Diego, CA).
RESULTS
8-Cl-adenosine inhibits proliferation in primary mouse keratinocytes in a dose-and time-dependent manner In this study we sought to determine whether 8-Cl-adenosine, an agent known to induce growth arrest and/or differentiation in transformed cells (Carlson et al, 2000; and nontransformed cells (Han et al, 1993) , could elicit growth arrest and/or differentiation in a nontransformed/nonimmortalized primary cell, whose principal function depends in part upon continuous proliferation. A 24 h exposure of keratinocytes to 8-Cl-adenosine inhibited [ 3 H]thymidine incorporation in a dose-dependent manner with an apparent IC 50 of 7.5 mM ( Fig 1A) . 8-Cladenosine inhibited growth of primary mouse keratinocytes within 1 h of treatment with a 70%±80% inhibition of [ 3 H]thymidine incorporation observed after 24 h ( Fig 1B) . Maximal inhibition was observed between 18 and 24 h ( Fig 1B) .
The growth inhibitory effects of 8-Cl-adenosine are completely reversible Previous studies have demonstrated that 8-Cl-adenosine exerts an irreversible inhibition of proliferation in colorectal cancer cells (Tagliaferri et al, 1988) . We sought to determine if the antiproliferative effects we observed in primary mouse keratinocytes exhibited a similar phenomenon. Treatment of keratinocytes with 8-Cl-adenosine for either 24 or 48 h followed by agonist removal and replenishment of fresh medium resulted in a reversible growth inhibition of these cells (Fig 2) . Not only did these cells reestablish their proliferative capabilities but the cells that had been treated with 8-Cl-adenosine for 24 h exhibited growth rates greater than those cells that had not been previously exposed to 8-Cl-adenosine.
8-Cl-adenosine induces a G 0 /G 1 cell cycle arrest We utilized¯ow cytometric analysis to address changes in cell cycle pro®le relative to cellular growth/proliferation in primary mouse keratinocytes. In pooled attached and detached cells, 8-Cladenosine induced a signi®cant increase in the population of keratinocytes in G 0 /G 1 concomitant with a decrease in the number of cells in S phase (Table I) . These results were similar to those observed in keratinocytes treated with TGF-b, a known inducer of G 0 /G 1 arrest in a number of cell systems (Hu et al, 1998) , including keratinocytes (Alexandrow and Moses, 1995) . A small but statistically signi®cant increase in the proportion of cells in G 2 /M was also detected in 8-Cl-adenosine-treated keratinocytes. On the other hand, there was no increase in the number of cells in the sub-G 0 /G 1 phase, generally considered to be indicative of apoptotic cells. In additional experiments, we examined the effect of 8-Cladenosine on attached cells only. Again, 8-Cl-adenosine decreased the proportion of cells in S phase and increased the percentage of cells in G 0 /G 1 (Table II) . These results were similar to the effects observed when the attached and detached cells were pooled and analyzed (Table I ) and were also once more similar to the effects of TGF-b.
8-Cl-adenosine does not cause keratinocyte differentiation Numerous agents that elicit growth arrest of keratinocytes also trigger their differentiation. Therefore, we sought to determine if 8-Cl-adenosine induced a differentiated phenotype in keratinocytes. We analyzed 8-Cl-adenosine-treated keratinocytes for either keratin-1 expression or transglutaminase activity, early and later differentiation markers, respectively. Keratinocytes were treated for 18 or 24 h with 8-Cl-adenosine and analyzed for keratin-1 expression by Western blot analysis. Figure 3(A) illustrates representative Western blots demonstrating that 8-Cladenosine did not increase expression of this differentiation marker. On the other hand, the positive controls, elevated extracellular Ca 2+ levels (125 mM) and 1,25-dihydroxyvitamin D 3 (10 nM), both inducers of differentiation in keratinocytes (reviewed in Bikle and Pillai, 1993) , increased keratin-1 protein expression ( Fig 3A) . PhosphorImager densitometric analysis revealed that Ca 2+ and 1,25-dihydroxyvitamin D 3 increased keratin-1 protein expression from 2-to 8-fold over control-treated keratinocytes ( Fig 3B) . 8-Cl-adenosine had no effect on keratin-1 protein expression. In addition, a 24 h exposure to 8-Cl-adenosine failed to alter transglutaminase activity, a marker of late-stage differentiation, at concentrations of either 10 or 25 mM. On the other hand, the positive control, elevated extracellular Ca 2+ levels (1 mM), increased transglutaminase activity 8-fold over that observed in control-treated keratinocytes (Fig 4) . A longer (48 h) exposure to 8-Cl-adenosine also failed to increase transglutaminase activity (0.65-fold T 0.08-fold over control), although again the positive control of elevated extracellular Ca 2+ levels (1 mM) stimulated activity (6.5-fold T 1.5-fold over control, n = 3; p < 0.001).
Potential mechanisms of 8-Cl-adenosine-induced growth arrest Recent data from the laboratory of Dr. Paul Cook has indicated that adenosine analogs can inhibit keratinocyte growth by a mechanism that requires uptake of the compounds into the cell (Brown et al, 2000) . To determine if a similar requirement for uptake of 8-Cl-adenosine exists, we examined the effect of the nucleoside transport inhibitor nitrobenzylthioinosine (NBTI) on 8-Cl-adenosine-induced growth arrest by¯ow cytometric analysis. We have previously shown that 100 mM NBTI inhibits more than 90% of the uptake of the nucleoside thymidine into keratinocytes (Griner and Bollag, 2000) . Preventing uptake of 8-Cl-adenosine into keratinocytes with NBTI blocked the ability of 8-Cladenosine to reduce the proportion of cells in the S phase and increase the percentage in G 0 /G 1 (Table III) . Thus, our results indicate that uptake of 8-Cl-adenosine into the cells is necessary for the compound to elicit growth arrest.
Regulation of G 0 /G 1 cell cycle arrest has been attributed to a number of cellular proteins, including p53, the CDK inhibitors (p21 WAF1/Cip1 , p27 Kip1 , and p57 Kip2 ), and the speci®c inhibitors of CDK4 and CDK6 (p16 INK4a , p15 INK4b , p18 INK4c , and p19 INK4d ), known as the INK4 proteins (Sherr, 1996) . We investigated the effect of 8-Cl-adenosine on p21 WAF1/Cip1 , because of its recognized importance to keratinocyte growth arrest (Missero et al, 1995 (Missero et al, , 1996 Di Cunto et al, 1998) . Western blot analysis of 8-Cladenosine-treated primary mouse keratinocytes revealed an increase in the levels of p21 WAF1/Cip1 protein above control-treated cultures at as early as 6 h of treatment (data not shown) with a pronounced 2-to 3-fold increase observed by 16±24 h of exposure ( Fig 5) .
DISCUSSION
It has become increasingly clear that the use of 8-Cl-cAMP or 8-Cl-adenosine for the control of cellular proliferation is not as simple as once believed. It now appears that this cAMP analog and its active metabolite exert differential effects on a wide variety of cells. In some cases, the antiproliferative effects of 8-Cl-cAMP are mediated by 8-Cl-adenosine (Van Lookeren Campagne et al, 1991; Scala et al, 1995) , whereas in some cell systems 8-Cl-cAMP inhibits growth independent of its conversion to 8-Cl-adenosine (Noguchi et al, 1998) . In any event, the signal transduction mechanisms by which either of these two agents induce their antiproliferative effects has not been clearly de®ned. We have sought to determine the effect of 8-Cl-adenosine on the growth of a nontransformed/ nonimmortalized cell system, primary cultures of mouse keratinocytes. We chose this cell system because in vivo keratinocytes must proliferate as part of their normal function; thus these cells represent a good model for investigating antiproliferative effects in a normal cell type.
8-Cl-adenosine inhibited growth in primary cultures of mouse keratinocytes in a dose-and time-dependent manner (Fig 1) . Interestingly, the effects of 8-Cl-adenosine on keratinocyte growth were completely reversible (Fig 2) . These ®ndings are in contrast to the irreversible growth inhibitory effects observed in the The sub-G 0 /G 1 population for the three treatments was not statistically different. The sub-G 0 /G 1 population for the three treatments was less than 1% of the population of cells. colorectal cancer cell line LS174T (Tagliaferri et al, 1988) and suggest the potential for differences in the mechanism by which this nucleoside inhibits growth in nontransformed versus transformed cells. Along these lines, 8-Cl-adenosine induces apoptosis in several colorectal cancer cell lines (Carlson et al, 2000) , whereas we did not detect any apoptosis in 8-Cl-adenosine-treated keratinocytes (Table I) . Interestingly, treatment with 8-Cl-adenosine for 24 h and its subsequent removal resulted in enhanced [ 3 H]thymidine incorporation relative to control cultures. This``rebound'' effect is probably due to the fact that keratinocyte proliferation decreases signi®cantly (but does not cease) once the cells attain con¯uence. Thus, if the cells are prevented from becoming completely con¯uent by 8-Cl-adenosine treatment, removal of the 8-Cladenosine-induced inhibition will lead to enhancement of DNA synthesis relative to the con¯uence-inhibited control cultures.
Flow cytometric analysis revealed that 8-Cl-adenosine induced a G 0 /G 1 arrest. This cell cycle arrest was associated with elevations in the cyclin-dependent kinase inhibitor p21 WAF1/CIP1 (Fig 5) . We do not know at this time if removal of 8-Cl-adenosine, a condition that releases keratinocytes from their apparent cell cycle arrest, results in a decline in the protein levels of p21 WAF1/Cip1 . Elevation in p21 WAF1/Cip1 protein is associated with differentiation in a number of cell systems (Jiang et al, 1994; Datto et al, 1995; Missero et al, 1995) . 8-Cl-adenosine-induced elevations in p21 WAF1/Cip1 protein, however, were not accompanied by keratinocyte differentiation, as determined by changes in keratin-1 expression or transglutaminase activity between 18 and 48 h of treatment (Figs 3, 4) . These results are similar to that observed with TGF-b (an inducer of p21 WAF1/Cip1 ) in that G 0 /G 1 arrest occurs without a concomitant induction of differentiation (Hu et al, 1998) . Dotto and colleagues, however, reported that p21 WAF1/Cip1knockout mouse keratinocytes exhibited a downregulation in the late-stage keratinocyte differentiation markers loricrin and involucrin (Missero et al, 1996) , suggesting that p21 WAF1/Cip1 is required for this stage of differentiation in keratinocytes. This effect was not observed in keratinocytes devoid of the closely related cyclindependent kinase inhibitor p27 Kip1 (Missero et al, 1996) . On the other hand, overexpression of p21 WAF1/Cip1 was also found to prevent differentiation marker expression (Di Cunto et al, 1998) . Thus, the exact role of p21 WAF1/Cip1 in the control of keratinocyte differentiation has yet to be clari®ed.
The mechanism through which 8-Cl-adenosine increases p21 WAF1/Cip1 expression and exerts its growth inhibitory effect is not clear. In studies in progress we have observed an 8-Cladenosine-elicited increase in keratinocyte p53 protein levels by approximately 4 h (data not shown). Similarly, in colorectal cancer cells both p53 and p21 WAF1/CIP1 levels increase upon treatment with 8-Cl-adenosine (Carlson et al, 2001) . p21 WAF1/CIP1 levels also are elevated in p53 mutant cells, however, (Drans®eld et al, unpublished observations), suggesting perhaps both p53-dependent and -independent mechanisms for the 8-Cl-adenosine-induced rise in p21 WAF1/CIP1 levels. In addition, results with the nucleoside transport inhibitor NBTI suggest that uptake of the compound into the cells is required. This ®nding is similar to the data of Brown et al (2000) , in which inhibition of entry of physiologic adenosine analogs (adenosine, AMP, ADP, and ATP) into human keratinocytes prevented the antiproliferative activity of these agents. Another similarity between our results and the data obtained The sub-G 0 /G 1 population for the four treatments was not statistically different. c Concentrations of 25 mM 8-Cl-adenosine and 100 mM NBTI were used. Figure 5 . 8-Cl-adenosine upregulates p21 WAF1/CIP1 protein levels. Primary mouse keratinocytes were treated with 8-Cl-adenosine (Ad, 25 mM) or control vehicle (C, H 2 O) for the indicated times and p21 WAF1/CIP1 protein expression was determined by Western blot and subsequent densitometric analysis as described in Materials and Methods (stippled bar, 16 h; gray bar, 24 h). Data represent the mean T SEM of ®ve to eight experiments expressed as fold over the control value of 1.0; #p < 0.05 compared to control-treated cells by a nonparametric Kruskal± Wallis ANOVA test. Inset: representative Western blot. with adenosine analogs is the reversibility of the effects (Fig 2 and Cook et al, 1995) . Nevertheless, there are distinct differences as well. For instance, Brown et al (2000) found that adenosine analogs arrested cells in S phase, whereas we observe 8-Cl-adenosineinduced arrest primarily in G 0 /G 1 (Tables I, II) . These disparities may or may not be due to differences in methodology (24 h vs 48 h incubations with agents and/or varying degrees of subcon¯uence) or species (mouse versus human). Cook and colleagues (Cook et al, 1995; Brown et al, 2000) also did not determine the effects of the adenosine analogs on markers of keratinocyte differentiation. Thus, it is not clear whether 8-Cl-adenosine inhibits growth via a novel mechanism or through one similar to that utilized by physiologic adenosine analogs.
Phase II trials of 8-Cl-cAMP for treatment of human cancers are in progress (McDaid and Johnston, 1999) . The mechanism of 8-Cl-cAMP inhibition of cancer cell proliferation is unknown but is likely to involve conversion of 8-Cl-cAMP to 8-Cl-adenosine (Van Lookeren Campagne et al, 1991; Han et al, 1993; Scala et al, 1995; Halgren et al, 2001; Yin et al, 2001) . Similarly, 8-Cl-cAMP induces apoptotic cell death in some cancer cell lines through its 8-Cl-adenosine metabolite (Halgren et al, 2001; Yin et al, 2001) . On the other hand, we have found that 8-Cl-cAMP is less potent than 8-Cl-adenosine at inhibiting normal keratinocyte proliferation (data not shown). In addition, our results suggest that 8-Cladenosine does not induce apoptosis in normal keratinocytes but instead causes a reversible G 0 /G 1 growth arrest. Therefore, whereas 8-Cl-adenosine may temporarily inhibit keratinocyte proliferation, the reversibility of this effect should preclude any long-term negative consequences. Indeed, in athymic mice in vivo administration of 8-Cl-adenosine inhibits tumor formation by a colorectal cancer cell line without signi®cant toxicity (Carlson et al, 2000) . Thus, by sparing the stem cells and/or transit-amplifying cells of the epidermis while triggering apoptosis in cancer cells, both 8-Cl-cAMP and its metabolite 8-Cl-adenosine should exhibit little skin toxicity and hopefully prove to be a useful therapy for treatment of human cancers.
Taken together, these data suggest (i) that 8-Cl-adenosine can inhibit growth of a nontransformed/nonimmortalized cell, primary mouse keratinocytes, and (ii) this growth inhibition is dissociated from the induction of the keratinocyte differentiation program. Thus, 8-Cl-adenosine represents a small nonpeptide molecule that, like TGF-b, is capable of arresting keratinocyte growth without eliciting differentiation. Finally, it should be noted that careful consideration must be applied when investigating the apparent cell speci®city and mechanisms by which the antiproliferative effects of 8-Cl-adenosine are exerted. 
